Reuters logo
BRIEF-FDA approves Synjardy XR tablets for adults with type 2 diabetes
December 12, 2016 / 8:59 PM / 9 months ago

BRIEF-FDA approves Synjardy XR tablets for adults with type 2 diabetes

Dec 12 (Reuters) - Eli Lilly And Co

* Synjardy XR can cause serious side effects, including Lactic Acidosis

* U.S. FDA approves Synjardy XR (Empagliflozin/Metformin hydrochloride extended-release) tablets for adults with type 2 diabetes Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below